StockSelector.com
  Research, Select, & Monitor Saturday, February 06, 2016 10:20:03 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
   Diversify with StockSelector.com
- the tools for short-term traders and long-term investors to find successful ideas to fit their strategies and to keep informed of the stocks you follow or hold. Take a macro look at the market and by industry, narrow down to specific stocks and the right time, then use our portfolio to monitor the stocks and be alerted of changes.


 Sector ETF's Price Change  
Consumer Discret Select Sector SPDR 70.16 (3.23%)
Consumer Staples Select Sector SPDR 49.63 (0.16%)
Energy Select Sector SPDR 55.94 (2.32%)
Financial Select Sector SPDR 20.95 (1.32%)
Healthcare Select Sector SPDR 64.40 (1.95%)
Industrial Select Sector SPDR 50.04 (0.95%)
Materials Select Sector SPDR 40.61 (1.14%)
Technology Select Sector SPDR 39.50 (2.81%)
Utilities Select Sector SPDR 46.57 0.32%

 Most Oversold Industry
 Auto Manufacturers - Major
These firms are some of the largest vehicle manufacturers in the world. They produce the obvious cars, trucks, buses, vans, and motorcycles. Recreational vehicles, mini-vans, luxury cars, components, and construction equipment are some of their other related items on the production lines. Many firms also offer financing of their goods and in a field tied to vehicle financing, one firm here offers mortgages and even auto and homeowner's insurance. They typically sell their product to the consumer through auto dealerships located domestically and abroad.


Michael Kors Beats
2/2/2016 6:55:00 AM



0.23%
Michael Kors Holdings Limited (KORS) reported third quarter earnings of $1.59 per share on revenue of $1.40 billion. The consensus earnings estimate was $1.46 per share on revenue of $1.36 billion for the quarter ending December 31, ... more

Seagate Beats
1/29/2016 8:00:04 AM


1.86%
Seagate Technology plc (STX) reported second quarter earnings of $0.82 per share on revenue of $2.99 billion. The consensus earnings estimate was $0.71 per share on revenue of $2.94 billion for the quarter ending December 31, 2015. ... more

Caterpillar Reports In-line
1/28/2016 7:30:00 AM



0.24%
Caterpillar, Inc. (CAT) reported fourth quarter earnings of $0.74 per share on revenue of $11.03 billion. The consensus earnings estimate was $0.69 per share on revenue of $11.4 billion for the quarter ending December 31, 2015. The ... more

QUALCOMM Beats by a Penny
1/27/2016 4:05:00 PM


3.59%
QUALCOMM Incorporated (QCOM) reported first quarter earnings of $0.97 per share on revenue of $5.78 billion. The consensus earnings estimate was $0.90 per share on revenue of $5.69 billion for the quarter ending December 31, 2015. ... more

Boeing Beats
1/27/2016 7:30:00 AM


0.85%
Boeing Co. (BA) reported fourth quarter earnings of $1.60 per share on revenue of $23.57 billion. The consensus earnings estimate was $1.35 per share on revenue of $23.55 billion for the quarter ending December 31, 2015. The Earnings ... more

Coach Reports In-line
1/26/2016 6:45:00 AM


2.88%
Coach Inc. (COH) reported second quarter earnings of $0.68 per share on revenue of $1.27 billion. The consensus earnings estimate was $0.65 per share on revenue of $1.28 billion for the quarter ending December 31, 2015. The Earnings ... more

 StockSelector's Top Ranked Stock
 Abiomed, Inc.
Positive Points:14
Negative Points:7
Abiomed, Inc. is a developer, manufacturer and marketer of medical products designed to safely and effectively assist or replace the pumping function of the failing heart. The company currently manufactures and sells the BVS-5000, a temporary heart assist device, which is approved by the U.S. Food and Drug Administration for the temporary treatment of all patients with failing but potentially recoverable hearts. The company is also engaged in research and development relating to other devices to support the pumping function of the heart.

 Potential Breakout Stock
 Eleven Biotherapeutics
Eleven Biotherapeutics, Inc. is engaged in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States. The company develops its therapeutics through AMP-Rx, a proprietary protein engineering platform. Its principal preclinical product candidate consist of EBI-005, a novel IL-1 receptor antagonist for the topical treatment of dry eye disease and allergic conjunctivitis, EBI-029, a novel inhibitor of the cytokine IL-6 for the treatment of certain retinal diseases, such as DME and EBI-028, a novel inhibitor of the cytokine IL-17 for the treatment of uveitis. Eleven Biotherapeutics, Inc. is based in Cambridge, United States.











Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Quotes are delayed by 15-20 minutes. Quotes provided by QuoteMedia

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2016 StockSelector.com. All rights reserved.